|
|
|
Insider
Information: |
Clancy Paul J |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
138,295 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$20,880,188 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
138,295 |
|
|
Total
Value |
$20,880,188 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Biogen Idec Inc |
BIIB |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Financial O... |
2019-07-11 |
90,447 |
2017-07-10 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Incyte Corp |
INCY |
Director |
2024-03-28 |
15,785 |
2019-03-29 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
14,701 |
2021-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
Director |
|
2021-09-30 |
4 |
A |
$68.78 |
$22,078 |
D/D |
321 |
7,621 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2011-03-05 |
4 |
D |
$71.15 |
$1,841,931 |
D/D |
(25,888) |
47,197 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-03-31 |
4 |
A |
$73.23 |
$21,017 |
D/D |
287 |
2,744 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2021-12-31 |
4 |
A |
$73.40 |
$25,176 |
D/D |
343 |
7,964 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-09-30 |
4 |
A |
$74.23 |
$19,745 |
D/D |
266 |
2,226 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2022-06-30 |
4 |
A |
$75.97 |
$24,386 |
D/D |
321 |
10,755 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2022-03-31 |
4 |
A |
$79.42 |
$25,891 |
D/D |
326 |
8,290 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2022-12-30 |
4 |
A |
$80.32 |
$23,614 |
D/D |
294 |
11,388 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2021-03-31 |
4 |
A |
$81.27 |
$24,218 |
D/D |
298 |
5,094 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2021-06-30 |
4 |
A |
$84.13 |
$23,809 |
D/D |
283 |
7,300 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-06-28 |
4 |
A |
$84.96 |
$20,136 |
D/D |
237 |
1,960 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-03-29 |
4 |
A |
$86.01 |
$17,460 |
D/D |
203 |
203 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-12-31 |
4 |
A |
$86.98 |
$24,441 |
D/D |
281 |
4,796 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-12-31 |
4 |
A |
$87.32 |
$20,171 |
D/D |
231 |
2,457 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-09-30 |
4 |
A |
$89.74 |
$23,332 |
D/D |
260 |
4,515 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2011-04-28 |
4 |
AS |
$98.75 |
$1,950,088 |
D/D |
(19,716) |
42,247 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2011-08-01 |
4 |
D |
$102.90 |
$85,922 |
D/D |
(835) |
41,412 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-06-30 |
4 |
A |
$103.97 |
$23,809 |
D/D |
229 |
4,255 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2018-02-08 |
4 |
S |
$116.31 |
$707,048 |
D/D |
(6,079) |
89,014 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2019-02-07 |
4 |
D |
$119.57 |
$715,148 |
D/D |
(5,981) |
87,328 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2012-02-01 |
4 |
AS |
$120.00 |
$2,568,000 |
D/D |
(21,400) |
21,168 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2019-07-11 |
4 |
D |
$124.20 |
$649,566 |
D/D |
(5,230) |
90,447 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2018-07-10 |
4 |
S |
$131.11 |
$687,148 |
D/D |
(5,241) |
93,309 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2019-02-28 |
4 |
D |
$132.93 |
$143,431 |
D/D |
(1,079) |
86,249 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2013-02-23 |
4 |
D |
$164.40 |
$332,252 |
D/D |
(2,021) |
30,699 |
0 |
- |
|
119 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|